Certified by Founder Lodge
Ambrosia Biosciences Inc.
United States - Boulder, CO
START UP
1 Disclosed Funding Rounds $16,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ambrosia Biosciences Inc. is a privately held drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 21 ,2024 | Series A | $16,000,000 | |
| December, 12 ,2024 | Series A | $25,000,000 |
Boulder Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Mondra | $13,206,500 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
